Lynn Anson‐Cartwright
Papers
3
Total Citations
44
H-Index
2
About
Dr. Lynn Anson‐Cartwright is a leading urologic oncologist whose research centers on the surgical management of testicular cancer, with a particular focus on retroperitoneal lymph node dissection (RPLND). Her major contributions lie in advancing robotic-assisted surgical techniques for both primary and post-chemotherapy testis cancer, demonstrating that minimally invasive approaches can achieve oncologic outcomes comparable to traditional open surgery. In her landmark 2021 study, she established the feasibility and safety of robotic RPLND, while her 2024 propensity-matched analysis provided robust evidence supporting robotic over open approaches for clinical stage II disease, with both papers accumulating 21 citations each. Dr. Anson‐Cartwright has also pioneered the use of lymph node density as a prognostic marker for relapse following primary RPLND, offering a novel tool for risk stratification. Her work has been instrumental in shifting the paradigm toward less invasive surgical options, improving recovery times and quality of life for young testicular cancer survivors. With over 40 combined citations across her most influential papers, she continues to shape evidence-based guidelines and train the next generation of robotic surgeons.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3